<SEC-DOCUMENT>0001558370-25-004264.txt : 20250401
<SEC-HEADER>0001558370-25-004264.hdr.sgml : 20250401
<ACCEPTANCE-DATETIME>20250401161020
ACCESSION NUMBER:		0001558370-25-004264
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250331
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250401
DATE AS OF CHANGE:		20250401

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coherus BioSciences, Inc.
		CENTRAL INDEX KEY:			0001512762
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				273615821
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36721
		FILM NUMBER:		25799708

	BUSINESS ADDRESS:	
		STREET 1:		C/O DENNIS M. LANFEAR
		STREET 2:		333 TWIN DOLPHIN DR, SUITE 600
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		(650) 649-3530

	MAIL ADDRESS:	
		STREET 1:		C/O DENNIS M. LANFEAR
		STREET 2:		333 TWIN DOLPHIN DR, SUITE 600
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioGenerics, Inc.
		DATE OF NAME CHANGE:	20110210
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>chrs-20250331x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.9.0.3 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 4/1/2025 5:55:35 AM -->
<!-- iXBRL Library version: 1.0.9062.16423 -->
<!-- iXBRL Service Job ID: f72ff698-ff5e-418a-963e-12177f693cde -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:chrs="http://www.coherus.com/20250331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title>COHERUS BIOSCIENCES, INC._March 31, 2025</title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityCentralIndexKey" id="Tc_TuPQ4yHL6kir91jIu_cprA_2_1">0001512762</ix:nonNumeric><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:AmendmentFlag" id="Tc_GlR9vYwRo0iQRbMEfA4SlA_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="chrs-20250331.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001512762</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-31</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:9.77pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1px solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_3f96ff4f_39b2_48c9_9ffa_187416705787"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:18pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:DocumentType" id="Narr_TiGN_ljrLEidbEMdZf9-WQ"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">of the Securities Exchange Act of 1934</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="Narr_PzIFdWvVIU6_eHtTlQLRbQ"><b style="font-weight:bold;">March 31, 2025</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:24pt;font-weight:bold;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityRegistrantName" id="Narr_SH6ZDKpAhk2Di9vqZkArVg">COHERUS BIOSCIENCES, INC.</ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_4fef730f_4ab3_41d5_9b95_011d505ca620"></a><a id="Tc_JIA9g78Qlk6Ueg6PZ2xIKg_1_0"></a><a id="Tc_yFo57GWKxEiEiPYFHjZ_Pg_1_2"></a><a id="Tc_bQPWA15QDkyyHX_q4xLiag_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.85%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_d_Uffm2rRkGQaH2kdOjY4w_0_0"><b style="font-size:9pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityFileNumber" id="Tc_p6USO9dDGEG9bLwE-9B-KA_0_2"><b style="font-size:9pt;font-weight:bold;">001-36721</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityTaxIdentificationNumber" id="Tc_24A1--WPiEu6pGTQh3GUFw_0_4"><b style="font-size:9pt;font-weight:bold;">27-3615821</b></ix:nonNumeric></p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:33.85%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(State or other jurisdiction</b><br/><b style="font-weight:bold;">of incorporation)</b></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Commission</b><br/><b style="font-weight:bold;">File Number)</b></p></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(IRS Employer</b><br/><b style="font-weight:bold;">Identification Number)</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityAddressAddressLine1" id="Narr_4k8z52QXWUCzTI57R0Sckg"><b style="font-weight:bold;">333 Twin Dolphin Drive</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityAddressAddressLine2" id="Narr_Vgw4dqR3l0uxIBhRpRm2mw"><b style="font-weight:bold;">Suite 600</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityAddressCityOrTown" id="Narr_B15YS2auBEqaNtq16HYKSw"><b style="font-weight:bold;">Redwood City</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityAddressStateOrProvince" id="Narr_NdESKO_lH06sLFFqM1G3OA"><b style="font-weight:bold;">CA</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:EntityAddressPostalZipCode" id="Narr_fAxsAr9F5kS3FSvKuYO6JQ"><b style="font-weight:bold;">94065</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Address of principal executive offices, including Zip Code)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code: (</b><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:CityAreaCode" id="Narr_h0VRRFZ7Tk-qYRDwJDzNqQ"><b style="font-weight:bold;">650</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:LocalPhoneNumber" id="Narr_kvyvWjd2f0yIOKgoqv-6xg"><b style="font-weight:bold;">649-3530</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:14pt;font-weight:bold;">N/A</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Former name or former address, if changed since last report)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_1df92469_f3ff_4402_ae86_b7c37a7d26ea"></a><a id="Tc_gYv-OnL36kSi1XohvFyyFw_0_1"></a><a id="Tc_7KvjGq-yEUWM3fr006jcpw_2_1"></a><a id="Tc_oU417FdqaUusyJmFw1zm9w_4_1"></a><a id="Tc_3jNd0i6jQUy4XHlRtWzOww_6_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Tc_9wcZikMEEkCYR8c45DivSA_0_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Tc_gu4TZg8XlkOlXEbmH06qgA_2_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Tc_vBAAgsUU20qsm3uvNVf5ow_4_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Tc_4eGmEJk29k2BTSyPP2bRxg_6_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><a id="_132bb9e4_a733_46a7_a748_975eae4dea5f"></a><a id="Tc__W62-NI4QUuIlptt_QcZtg_0_0"></a><a id="Tc_HVBHSqTd-UO7ZkogXR0X4A_0_2"></a><a id="Tc_G2XknrNwH0qyXcLljerrQQ_0_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:30.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading</b><br/><b style="font-weight:bold;">Symbol(s)</b></p></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:30.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange</b><br/><b style="font-weight:bold;">on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:35%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:Security12bTitle" id="Tc_nACKySBKdEeZ2SfFID5lLw_1_0"><b style="font-weight:bold;">Common&#160;Stock,&#160;$0.0001&#160;par&#160;value&#160;per&#160;share</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:30.42%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" name="dei:TradingSymbol" id="Tc_0K3GE1-RdUaQlDMGjw2ZWw_1_2"><b style="font-weight:bold;">CHRS</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:30.44%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_axcvIvoUwEe0TcMTbkOWfQ_1_4"><b style="font-weight:bold;">The Nasdaq Global Market</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Emerging growth company&#160;&#160;<ix:nonNumeric contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_d2bC3bwc3Ee7VQiX6l5luA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Calibri','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_2d993bee_2187_4e7f_9abe_635dd378a025"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Introductory Note</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">As previously announced, on December 2, 2024, Coherus BioSciences, Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into an Asset Purchase Agreement (the &#8220;UDENYCA Purchase Agreement&#8221;), by and between the Company and Intas Pharmaceuticals Ltd., a limited company incorporated in India (&#8220;Intas&#8221;). Pursuant to the terms and subject to the conditions set forth in the UDENYCA Purchase Agreement, the Company agreed to divest its UDENYCA&#174; (pegfilgrastim-cbqv) franchise to Intas (the &#8220;Transaction&#8221;).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 1.01.</b></span><b style="font-weight:bold;">Entry into a Material Definitive Agreement.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">On March 31, 2025, in connection with the privately negotiated repurchase transactions described in Item 8.01 below, the Company and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee (the &#8220;Trustee&#8221;), entered into a first supplemental indenture, dated as of March 31, 2025 (the &#8220;Supplemental Indenture&#8221;) to the Indenture, dated April 17, 2020 (the &#8220;Indenture&#8221;), governing the Company&#8217;s 1.500% Convertible Senior Subordinated Notes due 2026 (the &#8220;Convertible Notes&#8221;), with respect to certain amendments (the &#8220;Amendments&#8221;) to the Indenture. On March 31, 2025, the Company received consents to the Amendments from eligible holders as of the relevant record date in respect of a majority of the aggregate principal amount of the Convertible Notes then outstanding, determined in accordance with the Indenture. The Amendments modify the Indenture to permit the Transaction. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">The foregoing description of the Supplemental Indenture is a summary and is qualified in its entirety by reference to the Supplemental Indenture, a copy of which is attached hereto as Exhibit 4.1 and is incorporated by reference into this Item 1.01.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><a id="_cafa723c_3942_47b7_9791_850b0f55385f"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 8.01</b></span><b style="font-weight:bold;">Other Events.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">On April 1, 2025, the Company issued a press release (the &#8220;Press Release&#8221;) announcing that it had entered into privately negotiated transactions (the &#8220;Repurchases&#8221;) with certain holders of its Convertible Notes, pursuant to which the Company agreed to repurchase approximately $170 million aggregate principal amount of the Convertible Notes from such holders at a cash repurchase price equal to 100% of their principal amount, together with the accrued and unpaid interest to, but excluding, the date of repurchase. The Repurchases are conditioned upon, among other things, the closing of the Transaction. Following the closing of the Repurchases, approximately $60 million aggregate principal amount of Convertible Notes will remain outstanding. Following the closing of the Transaction, Coherus intends to conduct a repurchase offer for such remaining Convertible Notes pursuant to the Fundamental Change Repurchase Right (as defined in the Indenture) at a cash repurchase price equal to 100% of their principal amount, together with the accrued and unpaid interest to, but excluding, the date of repurchase. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">A copy of the Press Release is attached as Exhibit 99.1 to this Current Report on Form 8-K. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">This Current Report on Form 8-K does not constitute an offer to sell, or a solicitation of an offer to buy, any security and will not constitute an offer, solicitation, or sale in any jurisdiction in which such offering would be unlawful.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><a id="_457fc058_6680_42a8_abfe_06e2ffecd313"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 9.01</b></span><b style="font-weight:bold;">Financial Statements and Exhibits.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">(d)    Exhibits</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The following exhibits are filed as part of this report:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:10.86%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:89.13%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:10.86%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</span></p></td><td style="vertical-align:top;width:89.13%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Description</span></p></td></tr><tr><td style="vertical-align:top;width:10.86%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">4.1</p></td><td style="vertical-align:top;width:89.13%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="chrs-20250331xex4d1.htm"><span style="font-style:normal;font-weight:normal;">First Supplemental Indenture, dated March 31, 2025, between Coherus BioSciences, Inc. and U.S. Bank Trust Company, National Association, as trustee.</span></a></p></td></tr><tr><td style="vertical-align:top;width:10.86%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:89.13%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="chrs-20250331xex99d1.htm"><span style="font-style:normal;font-weight:normal;">Press Release, dated April 1, 2025</span></a></p></td></tr><tr><td style="vertical-align:top;width:10.86%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:top;width:89.13%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_6a8f2910_49aa_4249_83ca_d64e6391e95e"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:24.45pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:40.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.04%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Date: April 1, 2025</p></td><td style="vertical-align:top;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:48.02%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">COHERUS BIOSCIENCES, INC.</p></td></tr><tr><td style="vertical-align:bottom;width:50.04%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.38%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.64%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.04%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.38%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:40.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">/s/ Dennis M. Lanfear</p></td></tr><tr><td style="vertical-align:bottom;width:50.04%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.38%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:40.64%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Dennis M. Lanfear</p></td></tr><tr><td style="vertical-align:bottom;width:50.04%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.38%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:40.64%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>chrs-20250331xex4d1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 4/1/2025 05:55:33 AM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXHIBIT 4.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><font style="font-style:italic;font-weight:bold;">Execution Version</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">FIRST SUPPLEMENTAL INDENTURE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">THIS FIRST SUPPLEMENTAL INDENTURE, dated as of March 31, 2025 (this &#8220;<b style="font-weight:bold;">Supplemental Indenture</b>&#8221;), is by and among Coherus BioSciences, Inc., a Delaware corporation (the &#8220;<b style="font-weight:bold;">Company</b>&#8221;), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the &#8220;<b style="font-weight:bold;">Trustee</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WITNESSETH</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, the Company and the Trustee have previously executed and delivered that certain Indenture, dated as of April 17, 2020 (the &#8220;<b style="font-weight:bold;">Indenture</b>&#8221;), providing for the issuance of the Company&#8217;s 1.500% Convertible Senior Subordinated Notes due 2026 (the &#8220;<b style="font-weight:bold;">Notes</b>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, on December 2, 2024, the Company entered into an Asset Purchase Agreement (the &#8220;<b style="font-weight:bold;">Asset Purchase Agreement</b>&#8221;) with Intas Pharmaceuticals Ltd., a limited company incorporated in India;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, in connection with the transactions described in the Asset Purchase Agreement, the Company has obtained the consent of certain Holders of the Notes to certain amendments to the Indenture as set forth in Article I hereof (the &#8220;<b style="font-weight:bold;">Amendments</b>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, Section 9.02 of the Indenture provides that, with the consent of the Holders of a majority of the aggregate principal amount of the Notes then outstanding (the &#8220;<b style="font-weight:bold;">Requisite Consents</b>&#8221;), the Company and the Trustee may amend or supplement the Indenture or the Notes or waive compliance with any provision of the Indenture or the Notes, subject to the exceptions set forth in Section 9.02(A)(i) through (ix);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, the Company desires to amend certain provisions of the Indenture and the Notes, as set forth in Article I of this Supplemental Indenture;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, Requisite Consents to the Amendments have been validly delivered and not validly revoked by Holders and the Company has filed with the Trustee evidence of such Requisite Consents; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">WHEREAS, the Company hereby requests that the Trustee join with the Company in the execution of this Supplemental Indenture.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE I</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">AMENDMENT OF INDENTURE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Section 1.1</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendments to the Indenture</u>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:35.3pt;margin:0pt 0pt 12pt 0pt;">The Indenture shall be amended as set forth in this Section 1.1. &#160;Text that shall be added to the Indenture is <u style="border-bottom-style:solid;border-bottom-width:0.5pt;text-decoration-line:underline;text-decoration-style:double;">double underlined</u>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 18pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</font></font>Clause (A) of Section 7.01 of the Indenture (When the Company May Merge, Etc.) shall be amended and restated in full as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 75.6pt;">&#8220;(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i style="font-style:italic;">Generally</i>. The Company will not consolidate with or merge with or into, or (directly, or indirectly through one or more of its Subsidiaries) sell, lease or otherwise transfer, in one transaction or a series of transactions, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to another Person (a &#8220;<b style="font-weight:bold;">Business Combination Event</b>&#8221;), unless: (i) the resulting, surviving or transferee Person either (x) is the Company or (y) if not the Company, is a corporation (the &#8220;<b style="font-weight:bold;">Successor Corporation</b>&#8221;) duly organized and existing under the laws of the United States of America, any State thereof or the District of Columbia that expressly assumes (by executing and delivering to the Trustee, at or before the effective time of such Business Combination Event, a supplemental indenture pursuant to&#160;<b style="font-weight:bold;">Section 9.01(E)</b>) all of the Company&#8217;s obligations under this Indenture and the Notes; and (ii) immediately after giving effect to such Business Combination Event, no Default or Event of Default will have occurred and be continuing<u style="border-bottom-style:solid;border-bottom-width:0.5pt;text-decoration-line:underline;text-decoration-style:double;">; </u><i style="border-bottom-style:solid;border-bottom-width:0.5pt;font-style:italic;text-decoration-line:underline;text-decoration-style:double;">provided, however</i><u style="border-bottom-style:solid;border-bottom-width:0.5pt;text-decoration-line:underline;text-decoration-style:double;">, that the transactions contemplated by the Asset Purchase Agreement, dated as of December 2, 2024, by and between the Company and Intas Pharmaceuticals Ltd., a limited company incorporated in India, shall not be deemed to constitute a Business Combination Event</u>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE II</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">MISCELLANEOUS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Section 2.1</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Capitalized Terms</u>. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture and the rules of construction contained in the Indenture will apply equally to this Supplemental Indenture.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Section 2.2</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effect of Supplemental Indenture</u>. This Supplemental Indenture is a supplemental indenture within the meaning of the Indenture. The provisions of this Supplemental Indenture are intended with respect to the Notes to supplement those of the Indenture as in effect immediately prior to the execution and delivery hereof. The Indenture shall remain in full force and effect except to the extent that the provisions of the Indenture are expressly modified by the terms of this Supplemental Indenture with respect to the Notes. The Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects ratified, confirmed and approved and the Indenture, as supplemented and amended by this Supplemental Indenture, shall be read, taken and construed as one and the same instrument.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Section 2.3</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law</u>. THIS SUPPLEMENTAL INDENTURE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Section 2.4</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterpart Originals</u>.<font style="display:inline-block;width:18.02pt;"></font>This Supplemental Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile, PDF or other electronic transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile, PDF or other electronic transmission (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) shall constitute effective execution and delivery of this Supplemental Indenture as to</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">-2-</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">the other parties hereto shall be deemed to be their original signatures for all purposes. The Company agrees to assume all risks arising out of its use of digital signatures and electronic methods to submit communications to Trustee, including the risk of the Trustee acting on unauthorized instructions and the risk of interception and misuse by third parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="color:#010000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Section 2.5</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effectiveness</u>.<font style="display:inline-block;width:15.64pt;"></font>This Supplemental Indenture shall become effective and binding on the Company, the Trustee and every Holder of the Notes heretofore or hereafter authenticated and delivered under the Indenture upon the execution and delivery by the parties hereto of this Supplemental Indenture.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">[<i style="font-style:italic;">Remainder of page intentionally left blank</i>]</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">-3-</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the date first above written.</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:5.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:4.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:40.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee</p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:44.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ David Jason</p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:44.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Name: David Jason</p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:44.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Title:&#160;Vice President</p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">COHERUS BIOSCIENCES, INC.</p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:top;width:49.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:44.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Dennis M. Lanfear</p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:44.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Name: Dennis M. Lanfear</p></td></tr><tr><td style="vertical-align:top;width:50.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:44.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Title:&#160;Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>chrs-20250331xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 4/1/2025 05:55:33 AM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 6pt 0pt;"><b style="font-size:11pt;font-weight:bold;">EXHIBIT 99.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;"><img src="chrs-20250331xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:36.46pt;width:146.5pt;"></font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-style:italic;font-weight:bold;">&#8211; Remaining $60 Million of outstanding convertible notes to be repurchased post-close of pending UDENYCA divestiture &#8211;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><b style="font-size:11pt;font-weight:bold;">REDWOOD CITY, Calif., April 1, 2025</b><font style="font-size:11pt;"> -- Coherus BioSciences, Inc. (&#8220;Coherus&#8221; or the &#8220;Company,&#8221; NASDAQ: CHRS) announced today that it has entered into privately negotiated transactions (the &#8220;Repurchases&#8221;) with certain holders (the &#8220;Holders&#8221;) of its 1.500% Convertible Senior Subordinated Notes due 2026 (the &#8220;Convertible Notes&#8221;), pursuant to which the Company agreed to repurchase approximately $170 million aggregate principal amount of the Convertible Notes from such holders at a cash repurchase price equal to 100% of their principal amount, together with the accrued and unpaid interest to, but excluding, the date of repurchase.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">The Repurchases are conditioned upon, among other things, the closing of the previously announced divestiture of the UDENYCA (pegfilgrastim-cbqv) franchise pursuant to that certain </font><font style="font-size:11pt;">asset purchase agreement (the &#8220;Agreement&#8221;), dated as of December 2, 2024 between the Company and Intas Pharmaceuticals Ltd. (&#8220;Intas&#8221;), a limited company incorporated in India (the &#8220;Transaction&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">Following the closing of the Repurchases, approximately $60 million aggregate principal amount of Convertible Notes will remain outstanding. Following the closing of the Transaction, Coherus intends to conduct a repurchase offer for such remaining Convertible Notes pursuant to the Fundamental Change Repurchase Right (as defined in the </font><font style="font-size:11pt;">indenture, dated as of April 17, 2020 (the &#8220;Indenture&#8221;), between the Company and U.S. Bank Trust Company, National Association, as trustee (the &#8220;Trustee&#8221;)) at a cash repurchase price equal to 100% of their principal amount, together with the accrued and unpaid interest to, but excluding, the date of repurchase</font><font style="font-size:11pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">Coherus also announced today that the Holders party to the Repurchases, which constitute a majority of the aggregate principal amount of the outstanding Convertible Notes, have agreed to provide their consent (the &#8220;Requisite Consents&#8221;) to adopt certain proposed amendments (the &#8220;Amendments&#8221;) to the Indenture. In connection with the Requisite Consents, the Company and the Trustee will execute a supplemental indenture (the &#8220;Supplemental Indenture&#8221;) to the Indenture effecting the Amendments. The Amendments will modify the Indenture to permit the proposed transaction for the divestiture of UDENYCA.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><b style="font-size:11pt;font-weight:bold;">About&#160;Coherus BioSciences</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">Coherus is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI</font><sup style="font-size:8.25pt;vertical-align:top;">&#174;</sup><font style="font-size:11pt;">&#160;(toripalimab-tpzi), with growing revenues and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head &amp; neck, and other cancers. Our strategy is to grow sales of LOQTORZI in nasopharyngeal carcinoma and advance the development of new indications for toripalimab in combination with both our pipeline candidates as well as our partners&#8217;, driving multiple development and sales synergies from proprietary combinations.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">Coherus&#8217; immuno-oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer. Casdozokitug is a novel IL-27 antagonistic antibody currently being evaluated in three ongoing clinical studies: a Phase 1/2 study in advanced solid tumors including combination with toripalimab in NSCLC, a Phase 2 study in HCC, and a randomized Phase 2</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">study in HCC evaluating casdozokitug in combination with toripalimab and bevacizumab. CHS-114 is a highly selective, competitively positioned, cytolytic anti-CCR8 antibody currently in a Phase 1 study in patients with advanced solid tumors, including HNSCC and gastric cancer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">Coherus markets LOQTORZI, a novel next-generation PD-1 inhibitor, and UDENYCA</font><sup style="font-size:8.25pt;vertical-align:top;">&#174;</sup><font style="font-size:11pt;">&#160;(pegfilgrastim-cbqv), a biosimilar of Neulasta. In&#160;December 2024, Coherus announced the planned divestiture of its UDENYCA franchise. The transaction is expected to close early in the second quarter of 2025.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">Neulasta</font><sup style="font-size:8.25pt;vertical-align:top;">&#174;</sup><font style="font-size:11pt;">&#160;is a registered trademark of Amgen, Inc.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Forward-Looking Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">The statements in this press release include express or implied forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Repurchases, the Requisite Consents, the Supplemental Indenture and the proposed transaction between the Company and Intas that involve risks and uncertainties relating to future events and the future performance of the Company. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. &#160;Words such as &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;future,&#8221; &#8220;opportunity,&#8221; &#8220;likely,&#8221; &#8220;target,&#8221; variations of such words, and similar expressions or negatives of these words are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. You can also identify forward-looking statements by discussions of strategy, plans or intentions.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">Examples of such forward-looking statements include, but are not limited to, express or implied statements regarding: Coherus&#8217; business, the Agreement and related matters, including, but not limited to, the consummation of the Repurchases, the Requisite Consents and the Supplemental Indenture, the ability to satisfy the closing conditions to consummate the proposed transaction at all or in the estimated time frame; prospective performance and opportunities with respect to the Company and its pipeline; statements about revenue or sales growth; statements about development and sales synergies; the ability of the Company&#8217;s product candidates to enhance outcomes for cancer patients; statements about the potential uses of proceeds from the proposed divestiture transaction including with respect to the repurchase offer for remaining Convertible Notes following the closing of the divestiture transaction; statements about the Company&#8217;s ability to repay its indebtedness in the future and the assumptions underlying or relating to such statements.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">These forward-looking statements are based on the Company&#8217;s current plans, estimates and projections. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, assumptions and changes in circumstances, many of which are beyond the control of the Company. A number of important factors, including those described in this press release, could cause actual results to differ materially from those contemplated in any forward-looking statements. Factors that may affect future results and may cause these forward-looking statements to be inaccurate include, without limitation: uncertainties as to the timing for completion of the proposed transaction, including the Repurchases, the Requisite Consents and the Supplemental Indenture; uncertainties as to the Company&#8217;s ability to satisfy the conditions necessary to consummate the proposed UDENYCA divestiture; the possibility that competing offers will be made by third parties; the occurrence of any event, change or other circumstance that may give rise to a right of one or both of Intas and the Company to terminate the Agreement; the possibility that the proposed transaction may not be completed in the time frame expected by the Company or at all; the risk that the proposed transaction disrupts the Company&#8217;s current plans and operations or diverts the attention of the Company&#8217;s management or employees from ongoing business operations; the effects of the proposed transaction on relationships with the Company&#8217;s employees, suppliers, business or collaboration partners or governmental entities, or other third parties as a result of the proposed transaction; the ability to retain and hire key personnel; significant or unexpected costs, charges or expenses resulting from the</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">proposed transaction; the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the Company after the consummation of the proposed transaction; potential negative effects related to this announcement or the consummation of the proposed transaction on the market price of the Company&#8217;s common stock and/or the Company&#8217;s operating or financial results; and the nature, cost and outcome of any litigation and other legal proceedings, including any legal proceedings related to the proposed UDENYCA divestiture transaction.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">While the foregoing list of factors presented here is considered representative, no list should be considered to be a complete statement of all potential risks and uncertainties. There can be no assurance that the transaction described above will in fact be consummated in the manner described or at all. For a further discussion of these and other factors that could cause the Company&#8217;s future results to differ materially from any forward-looking statements see the section entitled &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 17, 2025, as updated by the Company&#8217;s subsequent periodic reports filed with the SEC and in other documents the Company files with the SEC, including the definitive proxy statement of the Company relating to the proposed transaction for the divestiture of UDENYCA filed with the SEC on January 28, 2025. Any forward-looking statements speak only as of the date of this press release and are made based on the current good faith beliefs and judgments of the Company&#8217;s management, and the reader is cautioned not to rely on any forward-looking statements made by the Company. Unless required by law, the Company is not under any duty and undertakes no obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">UDENYCA&#174; and LOQTORZI&#174;, whether or not appearing in large print or with the trademark symbol, are trademarks of Coherus, its affiliates, related companies or its licensors or joint venture partners unless otherwise noted. Trademarks and trade names of other companies appearing in this press release are, to the knowledge of Coherus, the property of their respective owners.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><b style="font-size:11pt;font-weight:bold;">No Offer or Solicitation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. &#160;No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Additional Information and Where to Find It</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">In connection with the proposed divestiture of UDENYCA, the Company filed with the SEC a definitive proxy statement on Schedule 14A on January 28, 2025, and it may also file other documents regarding the proposed transaction with the SEC. Promptly after filing its definitive proxy statement with the SEC, the Company started the process of mailing the definitive proxy statement and a proxy card to each stockholder entitled to vote at the special meeting relating to the proposed transaction.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO AND ANY DOCUMENTS INCORPORATED BY REFERENCE THEREIN, IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">INFORMATION ABOUT THE PROPOSED TRANSACTION, RELATED MATTERS AND THE PARTIES TO THE PROPOSED TRANSACTION.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">You may obtain a free copy of the proxy statement and other relevant documents (if and when they become available) that are or will be filed with the SEC for free at the SEC&#8217;s website at www.sec.gov. Copies of the documents filed with the SEC by the Company will be available free of charge on the Company&#8217;s website at https://investors.coherus.com/sec-filings or by contacting the Company&#8217;s Investor Relations Department at IR@coherus.com.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Coherus BioSciences Contact Information:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><font style="font-size:11pt;">For investors:</font><font style="font-size:11pt;"><br></font><font style="font-size:11pt;">Jodi Sievers</font><font style="font-size:11pt;"><br></font><font style="font-size:11pt;">VP, Investor Relations &amp; Corporate Communications</font><font style="font-size:11pt;"><br></font><font style="font-size:11pt;">IR@coherus.com</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>chrs-20250331xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chrs-20250331xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !) 24# 2(  A$! Q$!_\0
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M9F\)QJ+FB[H****DL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4<?R^[8\C'93@<S2^MTE*W7K]ZU_$^8K;]B2S$A,_BF9D]([, G\VKU;X=?
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MON1E@,ER_+&Y82BHM]=6_O=V>._$C]FK1_B5XKGUV\U2\M9Y8XXS'"JE1M7
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%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>chrs-20250331.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/1/2025 5:55:40 AM-->
<!--Modified on: 4/1/2025 5:55:40 AM-->
<xsd:schema targetNamespace="http://www.coherus.com/20250331" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:attributeFormDefault="unqualified" xmlns:srt="http://fasb.org/srt/2024" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:chrs="http://www.coherus.com/20250331" xmlns:snj="http://xbrl.sec.gov/snj/2024" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024" xmlns:rxp="http://xbrl.sec.gov/rxp/2024q3" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.coherus.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="chrs-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="chrs-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="chrs-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/rxp/2024q3" schemaLocation="https://xbrl.sec.gov/rxp/2024q3/rxp-2024q3.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/snj/2024" schemaLocation="https://xbrl.sec.gov/snj/2024/snj-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>chrs-20250331_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/1/2025 5:55:40 AM-->
<!--Modified on: 4/1/2025 5:55:40 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:roleRef roleURI="http://www.coherus.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="chrs-20250331.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:title="Extensible Enumeration Domain Members" />
  <link:definitionLink xlink:role="http://www.coherus.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="extended" xlink:title="99900 - Disclosure - Standard And Custom Axis Domain Defaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationDocumentAxis" xlink:label="dei_DocumentInformationDocumentAxis_1" xlink:title="dei_DocumentInformationDocumentAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentDomain" xlink:label="dei_DocumentDomain_1" xlink:title="dei_DocumentDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_DocumentInformationDocumentAxis_1" xlink:to="dei_DocumentDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_DocumentInformationDocumentAxis_1 To dei_DocumentDomain_1" order="1" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>chrs-20250331_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/1/2025 5:55:40 AM-->
<!--Modified on: 4/1/2025 5:55:40 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Securities Act File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>chrs-20250331_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/1/2025 5:55:40 AM-->
<!--Modified on: 4/1/2025 5:55:40 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="chrs-20250331.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#di" roleURI="http://xbrl.sec.gov/dei/role/document/DocumentInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <presentationLink xlink:role="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638790837407348937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName_638790837407348937" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638790837407348937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType_638790837407348937" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638790837407348937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber_638790837407348937" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638790837407348937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638790837407348937" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638790837407348937" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638790837407348937" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638790837407358951" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_638790837407358951" order="7" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638790837407358951" order="8" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode_638790837407358951" order="9" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber_638790837407358951" order="10" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications_638790837407358951" order="11" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial_638790837407358951" order="12" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638790837407358951" order="13" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638790837407358951" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638790837407358951" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag_638790837407358951" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle_638790837407368947" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol_638790837407368947" order="17" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName_638790837407368947" order="18" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638790837407368947" order="19" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638790837407368947" order="20" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638790837407368947" order="21" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638790837407368947" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638790837407368947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638790837407368947" order="23" use="optional" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/DocumentInformation" xlink:type="extended" xlink:title="995200 - Document - Document Information" xmlns="http://www.xbrl.org/2003/linkbase" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COHERUS BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-36721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3615821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">333 Twin Dolphin Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">649-3530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common&#160;Stock,&#160;$0.0001&#160;par&#160;value&#160;per&#160;share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CHRS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redwood City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001512762<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document Information<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">CIK</a></td>
<td class="text">0001512762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">COHERUS BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $F!@5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( $F!@5H!9#)^[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 28&!6M_4]'). 0  U@(
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M#34ZT,_,&AGGG5;K(/HC.9Q>7DVN>7>=,;>,O;@GK_2XEO%+W7P"4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 28&!6IE<G",0!@  G"<  !,
M             ( !X $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" !)@8%:!VMA (4$  !J$0  &               @($A"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 28&!6G?]XU(Y @  +P8  !@
M             ("!W P  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4
M Q0    ( $F!@5J?H!OPL0(  .(,   -              "  4L/  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ 28&!6I>*NQS     $P(   L
M     ( !)Q(  %]R96QS+RYR96QS4$L! A0#%     @ 28&!6M_4]'). 0
MU@(   \              ( !$!,  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( $F!@5J-]RQ:M    (D"   :              "  8L4  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $F!@5INIR2\'@$  %<$
M   3              "  7<5  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   *  H A (  ,86      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="chrs-20250331x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coherus.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="chrs-20250331x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995200 - Document - Document Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/DocumentInformation</Role>
      <ShortName>Document Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>chrs-20250331.xsd</File>
    <File>chrs-20250331_def.xml</File>
    <File>chrs-20250331_lab.xml</File>
    <File>chrs-20250331_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isRxp="true" original="chrs-20250331x8k.htm">chrs-20250331x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "chrs-20250331x8k.htm": {
   "nsprefix": "chrs",
   "nsuri": "http://www.coherus.com/20250331",
   "dts": {
    "schema": {
     "local": [
      "chrs-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2014/extensible-enumerations.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/rxp/2024q3/rxp-2024q3.xsd",
      "https://xbrl.sec.gov/snj/2024/snj-2024.xsd",
      "https://xbrl.sec.gov/snj/2024/snj-2024_def.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "chrs-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "chrs-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "chrs-20250331_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "chrs-20250331x8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 64,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.coherus.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "chrs-20250331x8k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ",
      "name": "dei:EntityFileNumber",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "chrs-20250331x8k.htm",
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/DocumentInformation",
     "longName": "995200 - Document - Document Information",
     "shortName": "Document Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "chrs-20250331x8k.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "rxp_A": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "A",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount",
        "terseLabel": "Amount"
       }
      }
     },
     "auth_ref": []
    },
    "country_AllCountriesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "AllCountriesDomain",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByGovernment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Countries [Domain]",
        "terseLabel": "All Countries"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_AllGovernmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "AllGovernmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByGovernment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Governments [Member]",
        "terseLabel": "All Governments"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_AllProjectsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "AllProjectsMember",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Projects [Member]",
        "terseLabel": "All Projects"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_AlternativeReportingRegime": {
     "xbrltype": "alternativeReportingRegimeItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "AlternativeReportingRegime",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alternative Reporting Regime",
        "terseLabel": "Alternative Reporting Regime"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "terseLabel": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Bonuses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Bonuses",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bonuses",
        "terseLabel": "Bonuses"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Cm": {
     "xbrltype": "conversionMethodItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Cm",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency Conversion Method",
        "terseLabel": "Curr. Conv. Method"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Co": {
     "xbrltype": "enumerationItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Co",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country",
        "terseLabel": "Country"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_CommunityAndSocial": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "CommunityAndSocial",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Community and Social Responsibility",
        "terseLabel": "Comm. Social Resp."
       }
      }
     },
     "auth_ref": []
    },
    "rxp_CountryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "CountryAxis",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByGovernment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country [Axis]",
        "terseLabel": "Country:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Dividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Dividends",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends",
        "terseLabel": "Dividends"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information:",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "terseLabel": "Document Information",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "CIK",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject",
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Entities [Member]",
        "terseLabel": "All Entities",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation",
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/DocumentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "terseLabel": "Reporting Currency",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "rxp_Fees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Fees",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees",
        "terseLabel": "Fees"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_GovernmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "GovernmentAxis",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByGovernment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Government [Axis]",
        "terseLabel": "Government:"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Gv": {
     "xbrltype": "enumerationItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Gv",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Government",
        "terseLabel": "Govt."
       }
      }
     },
     "auth_ref": []
    },
    "rxp_InfrastructureImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "InfrastructureImprovements",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Infrastructure Improvements",
        "terseLabel": "Infrastructure"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_K": {
     "xbrltype": "yesItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "K",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "In-kind",
        "terseLabel": "In-kind"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Km": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Km",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "In-kind Value Calculation",
        "terseLabel": "In-kind Calc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject",
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity:",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "rxp_M": {
     "xbrltype": "extractionMethodItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "M",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extraction Method",
        "terseLabel": "Ext. Method"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_P": {
     "xbrltype": "enumerationItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "P",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment Type",
        "terseLabel": "Type"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_PaymentsByCategoryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "PaymentsByCategoryTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments by Category [Table]",
        "terseLabel": "Payments:"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_PaymentsByGovernmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "PaymentsByGovernmentTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments by Government [Table]",
        "terseLabel": "Payments, by Government:"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_PaymentsByProjectTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "PaymentsByProjectTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments by Project [Table]",
        "terseLabel": "Payments, by Project:"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_PaymentsDetailTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "PaymentsDetailTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments Detail [Table]",
        "terseLabel": "Payments Detail:"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_PaymentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "PaymentsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject",
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments [Line Items]",
        "terseLabel": "Payments:"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_PmtAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "PmtAxis",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pmt [Axis]",
        "terseLabel": "#"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Pr": {
     "xbrltype": "enumerationItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Pr",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Project",
        "terseLabel": "Project"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "rxp_ProductionEntitlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "ProductionEntitlements",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Production Entitlements",
        "terseLabel": "Prod. Entitlements"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_ProjectAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "ProjectAxis",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Project [Axis]",
        "terseLabel": "Project:"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_R": {
     "xbrltype": "enumerationItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "R",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Resource",
        "terseLabel": "Resource"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Royalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Royalties",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalties",
        "terseLabel": "Royalties"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "rxp_Sg": {
     "xbrltype": "enumerationItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Sg",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment",
        "terseLabel": "Segment"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_Sn": {
     "xbrltype": "enumerationItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Sn",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/Detail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subnational Jurisdiction",
        "terseLabel": "Subnat. Juris."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "rxp_Taxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "Taxes",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes",
        "terseLabel": "Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "rxp_TotalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/rxp/2024q3",
     "localname": "TotalPayments",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/rxp/role/ByCategory",
      "http://xbrl.sec.gov/rxp/role/ByGovernment",
      "http://xbrl.sec.gov/rxp/role/ByProject"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Payments",
        "terseLabel": "Total Payments"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001558370-25-004264-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-25-004264-xbrl.zip
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M4G[%&;H2(X;/X9&(2;HBG(S)E6VR:\LF%/%ID)6ZI-8XS%)Q\>4OR:UL[T-
MH&<F5R!Y--@%V_*%P2F("FB@Y+WYLQF8Y@U-DR?)=3)(/H.J!*\S1.93$K,D
M70,\$<:V"994$L6_MX?89!98<(@55 JY<GE^B]K=WNR>Y]N,$C", R09<<%,
M]6HX!-.*[@6][5C$>8<"&&0FYO&]J,?YS2PD2T-$#PWL&)NL!?I_T#'LS8_;
M ^BL1WAO6JY4BA1)"IS,K"0V6'92T:T;!N300'_#I#<+\"Q8>& [T\J'&G;
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M=YZ/LLZ%36UV1%:TG]'H(</!OO^8.C,Y)[Y !=>*0K/EOP\%G>>.WC@1*68
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MWB?96\)\D+P4 7=-;F#"E4K1>X;B-)^V CL\1%I2 XX/9B#8T E:+Y:(CBA
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M='@?#3BR?R'VB/_ [/\!4$L! A0#%     @ 28&!6L3G_B@Q!   [1$  !$
M             ( !     &-H<G,M,C R-3 S,S$N>'-D4$L! A0#%     @
M28&!6N](4W F P  5 P  !4              ( !8 0  &-H<G,M,C R-3 S
M,S%?9&5F+GAM;%!+ 0(4 Q0    ( $F!@5I[$,K2G 0  .8O   5
M      "  ;D'  !C:')S+3(P,C4P,S,Q7VQA8BYX;6Q02P$"% ,4    " !)
M@8%:L3@. _<$  "-*P  %0              @ &(#   8VAR<RTR,#(U,#,S
M,5]P<F4N>&UL4$L! A0#%     @ 28&!6C]@#F=^&0  OK0  !0
M     ( !LA$  &-H<G,M,C R-3 S,S%X.&LN:'1M4$L! A0#%     @ 28&!
M6@!J4D_R#P  \&<  !<              ( !8BL  &-H<G,M,C R-3 S,S%X
M97@T9#$N:'1M4$L! A0#%     @ 28&!6@[S9UUG%@  X%8  !@
M     ( !B3L  &-H<G,M,C R-3 S,S%X97@Y.60Q+FAT;5!+!08     !P '
+ -4!   F4@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>chrs-20250331x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="chrs-20250331.xsd" xlink:type="simple"/>
    <context id="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512762</identifier>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_TuPQ4yHL6kir91jIu_cprA_2_1">0001512762</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_GlR9vYwRo0iQRbMEfA4SlA_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_TiGN_ljrLEidbEMdZf9-WQ">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_PzIFdWvVIU6_eHtTlQLRbQ">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_SH6ZDKpAhk2Di9vqZkArVg">COHERUS BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_d_Uffm2rRkGQaH2kdOjY4w_0_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_p6USO9dDGEG9bLwE-9B-KA_0_2">001-36721</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_24A1--WPiEu6pGTQh3GUFw_0_4">27-3615821</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_4k8z52QXWUCzTI57R0Sckg">333 Twin Dolphin Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_Vgw4dqR3l0uxIBhRpRm2mw">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_B15YS2auBEqaNtq16HYKSw">Redwood City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_NdESKO_lH06sLFFqM1G3OA">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_fAxsAr9F5kS3FSvKuYO6JQ">94065</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_h0VRRFZ7Tk-qYRDwJDzNqQ">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_kvyvWjd2f0yIOKgoqv-6xg">649-3530</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_9wcZikMEEkCYR8c45DivSA_0_0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_gu4TZg8XlkOlXEbmH06qgA_2_0">false</dei:SolicitingMaterial>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_vBAAgsUU20qsm3uvNVf5ow_4_0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_4eGmEJk29k2BTSyPP2bRxg_6_0">false</dei:PreCommencementTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_nACKySBKdEeZ2SfFID5lLw_1_0">Common&#160;Stock,&#160;$0.0001&#160;par&#160;value&#160;per&#160;share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_0K3GE1-RdUaQlDMGjw2ZWw_1_2">CHRS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Tc_axcvIvoUwEe0TcMTbkOWfQ_1_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_3_31_2025_To_3_31_2025_GzV3HCRfhUqLVjE5xKg2nQ"
      id="Narr_d2bC3bwc3Ee7VQiX6l5luA">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
